VALPARAISO | IVDiagnostics Inc., a biomedical technology company, recently was selected as a top 50 Innovator at the New York Venture Summit in New York City.
At the summit, start-ups meet venture capitalists and other investors.
IVDiagnostics presented its new approach in monitoring and diagnosing cancer, according to a news release. The company has developed a platform for a low-cost, circulating tumor cell scan without taking blood.
"With the ability to monitor and diagnose circulating tumor cells, clinicians will be able to better determine prognosis of blood-borne diseases and prescribe personalized medicine," President and CEO Frank Szczepanski said.
IVDiagnostics is focused on bringing new diagnostic technology to assist physicians with earlier detection of cancer and other blood-borne diseases. IVDiagnostics is an Indiana-based company with offices in West Lafayette and laboratories in Valparaiso.
For more information, visit www.ivdiagnostics.com.